Paper576161
Hypotensive sequelae of diazoxide and hydralazine therapy.
Henrich WL and 3 others. JAMA, 1977. Cited by 24 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Hypotensive sequelae of diazoxide and hydralazine therapy. Papers, record 576161. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/576161
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diazoxide | Major topic |
| Hydralazine | Major topic |
| Hypotension | Major topic |
| Adult | |
| Drug Synergism | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Pregnancy |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,840,160 | Antihypertensive effect of diazoxide given intravenously in small repeated doses. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6840160 | PubMed |
| 6,264,332 | Decrease of some metabolic and physiologic effects of diazoxide by propranolol in rat. | Naunyn Schmiedebergs Arch Pharmacol | 1981 | https://conductscience.org/library/papers/6264332 | PubMed |
| 3,123,620 | Hypertensive emergencies and urgencies: definition, recognition, and management. | J Gen Intern Med | 1988 | https://conductscience.org/library/papers/3123620 | PubMed |
| 1,503,669 | Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy. | Drug Saf | 1992 | https://conductscience.org/library/papers/1503669 | PubMed |
| 526,401 | Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/526401 | PubMed |
| 328,207 | Pharmacokinetics and response to diazoxide in renal failure. | Clin Pharmacokinet | 1977 | https://conductscience.org/library/papers/328207 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/576161
GET https://conductscience.org/api/papers/v1/576161/authors